...
首页> 外文期刊>Journal of Medicine: Clinical, Experimental and Theoretical >Insulin resistance and changes in the blood coagulation-fibrinolysis system after a glucose clamp technique in patients with type 2 diabetes mellitus.
【24h】

Insulin resistance and changes in the blood coagulation-fibrinolysis system after a glucose clamp technique in patients with type 2 diabetes mellitus.

机译:2型糖尿病患者采用葡萄糖钳夹技术后的胰岛素抵抗和血液凝固-纤维蛋白溶解系统的变化。

获取原文
获取原文并翻译 | 示例

摘要

We investigated the relationship between changes in insulin resistance and blood coagulation-fibrinolysis following institution of a glucose clamp (GC) in patients with type 2 diabetes mellitus. We studied 35 type 2 diabetic patients (19 males and 16 females, mean age at 58.3 +/- 11.9 years) and 10 healthy subjects. The hyperinsulinemic euglycemic GC technique was performed using on artificial pancreas. The degree of insulin resistance was determined from the glucose infusion rate (GIR) calculated from the GC technique. The GIR in type 2 diabetic patients was markedly reduced compared to that in healthy subjects. The GIR was significantly and negatively correlated with the body mass index and the serum concentrations of the fasting immunoreactive insulin (FIRI). The plasma concentrations of thrombomodulin (TM) and tissue plasminogen activator (tPA) in the diabetic patients were significantly higher than those in the healthy subjects. The plasma concentrations of plasminogen activator inhibitor 1 in the diabetic patients tended toward higher than those in the healthy subjects. The elevated plasma concentrations of TM and tPA in diabetes were significantly lowered following a GC technique. Patients with advanced nephropathy had significant higher concentrations of TM and tPA compared to healthy subjects. We concluded that diabetic patients have abnormalities in the blood coagulation-fibrinolytic system that can be improved by the GC technique.
机译:我们研究了在2型糖尿病患者中应用葡萄糖钳位(GC)后胰岛素抵抗变化与凝血-纤维蛋白溶解之间的关系。我们研究了35位2型糖尿病患者(男19例,女16例,平均年龄58.3 +/- 11.9岁)和10名健康受试者。高胰岛素正常血糖GC技术是在人造胰腺上使用的。胰岛素抵抗的程度由GC技术计算得出的葡萄糖输注速率(GIR)确定。与健康受试者相比,2型糖尿病患者的GIR明显降低。 GIR与体重指数和空腹免疫反应性胰岛素(FIRI)的血清浓度呈显着负相关。糖尿病患者的血栓调节蛋白(TM)和组织纤溶酶原激活剂(tPA)的血浆浓度显着高于健康受试者。糖尿病患者中的纤溶酶原激活物抑制剂1的血浆浓度趋于高于健康受试者。采用GC技术后,糖尿病患者TM和tPA的血浆浓度升高明显降低。与健康受试者相比,晚期肾病患者的TM和tPA浓度显着较高。我们得出的结论是,糖尿病患者的凝血-纤溶系统异常,可以通过GC技术加以改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号